Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/634   
Active ingredient: S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinyl-GNNDESNISFKEK
Indication: Treatment of pancreatic cancer
Sponsor: MBiotec GmbH
Höhenweg 13, 82229 Seefeld, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Orphan designation EMEA/OD/101/08 (2009)4056 of 15/05/2009